Incannex Healthcare Inc. (IXHL): Free Cash Flow
-$12.88M
Year ended 2026-06-30
-$3.19M
Trailing 12 months to 2026-09-30
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | -$12.88M | n/m | 2026-09-25, From 2025-07-01 |
| 2025-06-30 | -$12.52M | n/m | 2026-09-25, From 2024-07-01 |
| 2024-06-30 | -$16.12M | n/m | 2025-09-29, From 2023-07-01 |
| 2023-06-30 | -$11.06M | n/a | 2024-09-30, From 2022-07-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Incannex Healthcare Inc. (IXHL) | 2026-06-30 | -$12.88M | n/m |
| Abbott Laboratories (ABT) | 2025-12-31 | $7.39B | +16.4% |
| Bristol Myers Squibb Co (BMY) | 2025-12-31 | $12.85B | -7.9% |
| Eli Lilly & Co (LLY) | 2025-12-31 | $8.97B | +138.6% |
| Pfizer Inc (PFE) | 2025-12-31 | $9.07B | -7.7% |
| Johnson & Johnson (JNJ) | 2025-12-28 | $19.70B | -0.7% |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $28.84M | +101.3% |
| Merck & Co., Inc. (MRK) | 2025-12-31 | $12.36B | -31.7% |
| Lisata Therapeutics, Inc. (LSTA) | 2025-12-31 | -$15.98M | n/m |
Compare IXHL, ABT, BMY, LLY side by side · Screen every company in Pharmaceutical Preparations ↗